Bioelectron Technology Corporation

Conopco, Inc.

Edison Pharmaceuticals, Inc.

Dana Davis

Andrew W Hinman

William Dvorak Shrader

Viktoria Kheifets

Provided herein are methods and compositions comprising resorcinol derivatives for the use of treating, regulating or preventing a skin condition characterized by oxidative stress or a degenerative process. Methods of preventing, lightening or reducing the appearance of visible discontinuities of the skin resulting from skin pigmentation, skin aging, or other disorders are also disclosed.

Resorcinol compounds for dermatological use

Disclosed herein are phenazine-3-one and phenothiazine-3-one derivative compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases of aging.

Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders

Disclosed herein are resorufin derivative compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases of aging. 

Resorufin derivatives for treatment of oxidative stress disorders

Disclosed herein are resorufin derivative compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases of aging.

Growing community of inventors

Sunnyvale, CA, United States of America

Dana Davis